马萨诸塞州看到生物技术复苏, 尽管房地产盈余, 刺激了西方质量的制造业。 Massachusetts sees biotech recovery despite real estate surplus, boosting manufacturing in Western Mass.

马萨诸塞州在大波士顿面临生命科学房地产盈余,空缺率高,建筑停工,但最近的租赁活动预示着审慎复苏。 Massachusetts faces a life sciences real estate surplus in Greater Boston, with high vacancies and stalled construction, but recent leasing activity signals cautious recovery. 尽管联邦资金、风险资本和政策不确定性不断下降,公司仍在扩大,特别是在Waltham和Kendall广场。 Despite declining federal funding, venture capital, and policy uncertainty, companies are still expanding, especially in Waltham and Kendall Square. 国家正在转向西马萨诸塞州,用于生物制造、利用基础设施和降低成本。 The state is pivoting to Western Massachusetts for biomanufacturing, leveraging infrastructure and lower costs. 马萨诸塞生命科学中心正通过劳动力方案、2035年基金和生物促进倡议,领导各项工作,以推动制造业和吸引投资。 The Massachusetts Life Sciences Center is leading efforts through workforce programs, the 2035 Fund, and the Bio Boost initiative to boost manufacturing and attract investment. 虽然挑战依然存在,但有针对性的支持和战略扩张旨在维持国家在生物技术方面的全球领导地位。 While challenges remain, targeted support and strategic expansion aim to sustain the state’s global leadership in biotech.